Gabay Avraham (CIK 1777328) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell ORMP (73,360 shares), Buy ORMP (95,889 shares), Buy ORMP (19,000 shares), Buy ORMP (81,216 shares), Buy ORMP (115,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Sell | 73,360 | $330,744 |
| 2026-03-18 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Buy | 95,889 | $0 |
| 2026-01-29 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Buy | 19,000 | $0 |
| 2026-01-02 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Buy | 81,216 | $0 |
| 2026-01-02 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Buy | 115,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Buy | 34,000 | $0 |
| 2025-02-11 | ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | Buy | 42,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02